| Dr Robin Jacob, MD | |
|
1 Medical Center Blvd, Cookeville, TN 38501-4294 | |
| (931) 783-2497 | |
| (931) 526-6760 |
| Full Name | Dr Robin Jacob |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 1 Medical Center Blvd, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962652487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 51561 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cookeville Regional Medical Center | Cookeville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cookeville Regional Medical Center | 7810805736 | 28 |
News Archive
Rather than covering the entire genome, the microarray focuses on suspect regions of chromosomes for signs of deleted genetic material known to play a role in the cancer.
A study published in the journal Science Translational Medicine proposes that preventative treatment with affordable and safe antibiotics in people living in areas with intense malaria transmission has the potential to act as a 'needle-free' natural vaccine against malaria and may likely provide an additional valuable tool for controlling and/or eliminating malaria in resource-poor settings.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.
› Verified 5 days ago
| Entity Name | Cookeville Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275531956 PECOS PAC ID: 7810805736 Enrollment ID: O20040921001310 |
News Archive
Rather than covering the entire genome, the microarray focuses on suspect regions of chromosomes for signs of deleted genetic material known to play a role in the cancer.
A study published in the journal Science Translational Medicine proposes that preventative treatment with affordable and safe antibiotics in people living in areas with intense malaria transmission has the potential to act as a 'needle-free' natural vaccine against malaria and may likely provide an additional valuable tool for controlling and/or eliminating malaria in resource-poor settings.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robin Jacob, MD 140 W 7th St, Cookeville, TN 38501-1726 Ph: (931) 783-5582 | Dr Robin Jacob, MD 1 Medical Center Blvd, Cookeville, TN 38501-4294 Ph: (931) 783-2497 |
News Archive
Rather than covering the entire genome, the microarray focuses on suspect regions of chromosomes for signs of deleted genetic material known to play a role in the cancer.
A study published in the journal Science Translational Medicine proposes that preventative treatment with affordable and safe antibiotics in people living in areas with intense malaria transmission has the potential to act as a 'needle-free' natural vaccine against malaria and may likely provide an additional valuable tool for controlling and/or eliminating malaria in resource-poor settings.
pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).
A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.
› Verified 5 days ago
Scott F Reising, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Stacy David Brewington, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Mark Arden Pierce, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 145 W 4th St, Suite 201, Cookeville, TN 38501 Phone: 931-783-2902 Fax: 931-783-2219 | |
Michael Blaine Lenhart, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 228 West 4th St, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 | |
Dr. Toney Britton Hudson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 N Washington Ave, Ste 165, Cookeville, TN 38501 Phone: 931-526-1604 Fax: 931-526-7378 | |
James Chike Ezi-ashi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 438 N Whitney Ave, Cookeville, TN 38501 Phone: 931-783-2616 Fax: 931-783-2610 | |
Dr. Brian Keith Dockery, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 228 W 4th St, Suite 200, Cookeville, TN 38501 Phone: 931-372-0405 Fax: 931-372-0463 |